Prostate cancer prevention and the VITAL study data

Posted on November 11, 2018 by Sitemaster

Two sets of data from the 5-year-long VITamin D and OmegA-3 TriaL (VITAL) were published this week in the New England Journal of Medicine. … READ MORE …

Filed under: Diagnosis, Prevention, Risk | Tagged: , , , , | 9 Comments »

Major trial confirms value of zoledronic acid dosed every 3 months in preventing pain, SREs

Posted on June 17, 2015 by Sitemaster

An interesting paper that we managed to miss at the recent annual meeting of the American Society of Clinical Oncology (ASCO) provided the results of a large, randomized clinical trial of the use of zoledronic acid, carried out by the Cancer and Leukemia Group B cooperative trial group. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: , , , , , , , | Leave a comment »

Acid-suppressive therapy + ketoconazole in men with CRPC

Posted on October 7, 2010 by Sitemaster

Ketoconazole has long been used as a “third-line” agent in men with castration-resistant prostate cancer (CRPC) who have progressive disease after standard forms of hormonal therapy. For some patients, ketoconazole can be clinically effective and cost-effective compared to other clinical options. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , | 5 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives